Live! #20 — Commercializing Medical Devices in a Post-Brexit World

Although the date of Brexit has passed us, the UK continues to modify its stance for manufacturers’ requirements. In this session, we will dive into the new proposals and how they affect you and your medical devices. We will explore the implications of the CA mark (and its comparability to the CE mark), the UK’s position and stated reversal on EU MDR/EU IVDR, and the expected timelines and grace periods for compliance.

This session will contain critical information for any decision-makers doing business in the UK or Europe in the continually turbulent post-Brexit world.

Here's the panel:

Ibim Tariah, Ph.D. - VP of EU MDR and IVDR Consulting Services (Former BSI Technical Director of Medical Devices through 2019; 21 years at BSI) Nancy Morrison – Exec. Director, Regulatory and Quality Consulting Services, and leader of R&Q EU MDR Leadership Council, R&Q Ed Ball - Senior Associate, Maetrics Patrick Mahoney – Principal Specialist, R&Q

Moderator:

Lisa Casavant — Cofounder and Chief Strategy Officer, R&Q

R&Q's mission is to improve people's lives by providing industry-leading regulatory and quality consulting and engineering for medical devices, IVDs, and combination products. We help companies bring safe and effective products to market… and keep them there. Our team of 200+ consultants and counting have served over 300 companies around the globe. Subscribe to our blog, view our service offerings, watch free webinars, and more at RQTeam.com.

The and means more.